Working with its clients to ensure a successful outcome in terms of market access, Grove consultants based in Slovenia provide expert advice in three key areas:
Reimbursement is handled by two key parties in the Slovenian market: the Health Insurance Institute of Slovenia (ZZZS) is the decision-maker for medicine reimbursement and pricing; with the reimbursement of other health technologies decided by the Health Council at the Ministry of Health.
Although there are some common features, the criteria applied to reimbursement decision-making differ between the two institutions.
The Agency for Medicinal Products and Medical Devices (JAZMP) is the pricing authority for medicinal products. It works relatively quickly and efficiently, and regulation is straightforward and transparent.
Although recognized as being more all-inclusive than is the case in some markets, research shows that there is a need for further reform of the reimbursement policy in Slovenia. Any reform of the reimbursement process must be undertaken within the context of a review of the national healthcare priorities.
The relatively transparent and predictable local regulatory environment requires careful navigation. With experienced locally based consultants, Grove can assist with: